Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 1
2007 1
2008 2
2010 2
2011 6
2012 12
2013 8
2014 14
2015 10
2016 12
2017 15
2018 15
2019 9
2020 12
2021 9
2022 13
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism.
Vescini F, Borretta G, Chiodini I, Boniardi M, Carotti M, Castellano E, Cipriani C, Eller-Vainicher C, Giannini S, Iacobone M, Salcuni AS, Saponaro F, Spiezia S, Versari A, Zavatta G, Mitrova Z, Saulle R, Vecchi S, Antonini D, Basile M, Giovanazzi A, Paoletta A, Papini E, Persichetti A, Samperi I, Scoppola A, Novizio R, Calò PG, Cetani F, Cianferotti L, Corbetta S, De Rimini ML, Falchetti A, Iannetti G, Laureti S, Lombardi CP, Madeo B, Marcocci C, Mazzaferro S, Miele V, Minisola S, Palermo A, Pepe J, Scillitani A, Tonzar L, Grimaldi F, Cozzi R, Attanasio R. Vescini F, et al. Among authors: versari a. Endocr Metab Immune Disord Drug Targets. 2023 Dec 23:e141223224531. doi: 10.2174/0118715303260423231122111705. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 38644730
A case of 18p chromosomal deletion encompassing GNAL in a patient with dystonia-parkinsonism.
Di Rauso G, Cavallieri F, Monfrini E, Fraternali A, Fioravanti V, Grisanti S, Gessani A, Campanini I, Merlo A, Toschi G, Napoli M, Pascarella R, Silipigni R, Finelli P, Paul JJ, Bauer P, Versari A, Di Fonzo A, Valzania F. Di Rauso G, et al. Among authors: versari a. J Mov Disord. 2024 Jan 23. doi: 10.14802/jmd.23222. Online ahead of print. J Mov Disord. 2024. PMID: 38258373 Free article. No abstract available.
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database.
Panzuto F, Partelli S, Campana D, de Braud F, Spada F, Cives M, Tafuto S, Bertuzzi A, Gelsomino F, Bergamo F, Marcucci S, Mastrangelo L, Massironi S, Appetecchia M, Filice A, Badalamenti G, Bartolomei M, Amoroso V, Landoni L, Rodriquenz MG, Valente M, Colao A, Isidori A, Fanciulli G, Bollina R, Ciola M, Butturini G, Marconcini R, Arvat E, Cinieri S, Berardi R, Baldari S, Riccardi F, Spoto C, Giuffrida D, Gattuso D, Ferone D, Rinzivillo M, Bertani E, Versari A, Zerbi A, Lamberti G, Lauricella E, Pusceddu S, Fazio N, Dell'Unto E, Marini M, Falconi M. Panzuto F, et al. Among authors: versari a. Endocrine. 2024 Apr;84(1):42-47. doi: 10.1007/s12020-023-03649-4. Epub 2024 Jan 4. Endocrine. 2024. PMID: 38175391 Free PMC article. Review.
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study.
Muratore F, Marvisi C, Castrignanò P, Croci S, Bonacini M, Boiardi L, Ricordi C, Galli E, Besutti G, Spaggiari L, Versari A, Giorgi Rossi P, Pipitone N, Salvarani C. Muratore F, et al. Among authors: versari a. Semin Arthritis Rheum. 2024 Feb;64:152351. doi: 10.1016/j.semarthrit.2023.152351. Epub 2023 Dec 20. Semin Arthritis Rheum. 2024. PMID: 38142617
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.
Federico M, Fortpied C, Stepanishyna Y, Gotti M, van der Maazen R, Cristinelli C, Re A, Plattel W, Lazarovici J, Merli F, Specht L, Schiano de Colella JM, Hutchings M, Versari A, Edeline V, Stamatoulas A, Girinsky T, Ricardi U, Aleman B, Meulemans B, Tonino S, Raemaekers J, André M. Federico M, et al. Among authors: versari a. J Clin Oncol. 2024 Jan 1;42(1):19-25. doi: 10.1200/JCO.23.01745. Epub 2023 Nov 15. J Clin Oncol. 2024. PMID: 37967311 Clinical Trial.
Author Correction: Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson's disease.
Gessani A, Cavallieri F, Fioravanti V, Campanini I, Merlo A, Di Rauso G, Damiano B, Scaltriti S, Bardi E, Corni MG, Antonelli F, Cavalleri F, Molinari MA, Contardi S, Menozzi E, Fraternali A, Versari A, Biagini G, Fraix V, Pinto S, Moro E, Budriesi C, Valzania F. Gessani A, et al. Among authors: versari a. Sci Rep. 2023 Aug 17;13(1):13399. doi: 10.1038/s41598-023-39958-x. Sci Rep. 2023. PMID: 37591892 Free PMC article. No abstract available.
Levodopa responsive asymmetric parkinsonism as clinical presentation of progranulin gene mutation.
Biagioli N, Cavallieri F, Marti A, Di Rauso G, Fioravanti V, Monfrini E, Gasparini F, Beltrami D, Grisanti S, Rossi J, Toschi G, Fraternali A, Versari A, Napoli M, Pascarella R, Di Fonzo A, Valzania F. Biagioli N, et al. Among authors: versari a. J Neurol Sci. 2023 Aug 15;451:120737. doi: 10.1016/j.jns.2023.120737. Epub 2023 Jul 17. J Neurol Sci. 2023. PMID: 37487280 No abstract available.
Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson's disease.
Gessani A, Cavallieri F, Fioravanti V, Campanini I, Merlo A, Di Rauso G, Damiano B, Scaltriti S, Bardi E, Corni MG, Antonelli F, Cavalleri F, Molinari MA, Contardi S, Menozzi E, Fraternali A, Versari A, Biagini G, Fraix V, Pinto S, Moro E, Budriesi C, Valzania F. Gessani A, et al. Among authors: versari a. Sci Rep. 2023 Jul 15;13(1):11462. doi: 10.1038/s41598-023-38555-2. Sci Rep. 2023. PMID: 37454168 Free PMC article.
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial.
Zamagni E, Oliva S, Gay F, Capra A, Rota-Scalabrini D, D'Agostino M, Belotti A, Galli M, Racca M, Zambello R, Gamberi B, Albano D, Bertamini L, Versari A, Grasso M, Sgherza N, Priola C, Fioritoni F, Patriarca F, De Cicco G, Villanova T, Pascarella A, Zucchetta P, Tacchetti P, Fanti S, Mancuso K, Barbato S, Boccadoro M, Musto P, Cavo M, Nanni C. Zamagni E, et al. Among authors: versari a. EClinicalMedicine. 2023 Jun 9;60:102017. doi: 10.1016/j.eclinm.2023.102017. eCollection 2023 Jun. EClinicalMedicine. 2023. PMID: 37396807 Free PMC article.
138 results